TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01153984 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03247556 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT03719495 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03057392 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03179800 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03619941 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03413046 — Safety Biomarker (SAF): IL-6 and IL-10
Study NCT04322630 — Predictive Biomarker (PRD): MERTK mRNA
Genes: MERTK; MER
Study NCT00816127 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02575196 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00151918 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT02597738 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT00242203 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03227731 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01693744 — Predictive Biomarker (PRD): PHEX mRNA
Genes: PHEX; PEX
Study NCT02300623 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02300623 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00464919 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00977106 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03231670 — Predictive Biomarker (PRD): TLR5 mRNA
Genes: TLR5; TIL3
Study NCT03030066 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03030066 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study NCT01731587 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT02010762 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02403492 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01068041 — Predictive Biomarker (PRD): PHC3 mRNA
Genes: PHC3; EDR3; PH3
Study NCT03879317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00032019 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02306187 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01839188 — Predictive Biomarker (PRD): HEXA mRNA
Genes: HEXA
Study NCT01839188 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT01726322 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00128622 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01485965 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT01245660 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01245660 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01245660 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02949037 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01472601 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00940342 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02500199 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00060866 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04167644 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02968043 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01306942 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01306942 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT05087277 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03169556 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03529760 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02717000 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00003797 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01001377 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04175353 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02319148 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03280485 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT04558307 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02469753 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04580667 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT00017732 — Predictive Biomarker (PRD): DHCR7 mRNA
Genes: DHCR7; D7SR
Study NCT00003648 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study NCT02123121 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT04929366 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT04929366 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT00447460 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01461954 — Predictive Biomarker (PRD): FST mRNA
Genes: FST
Study NCT02427594 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03472378 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study NCT03472378 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT02585349 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study NCT02585349 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT03240302 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study NCT03240302 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01506947 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03524456 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02502253 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02503943 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01627119 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study NCT03601104 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03601104 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03301961 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01236703 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01236703 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04179968 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00050999 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00874289 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00874289 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03600558 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01865617 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03591757 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT00633581 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03741244 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03741244 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02603315 — Predictive Biomarker (PRD): CD74 mRNA
Genes: CD74; DHLAG
Study NCT03417544 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01375322 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01375322 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00000391 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00322933 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04478084 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04456608 — Predictive Biomarker (PRD): CYP4F2 mRNA
Genes: CYP4F2
Study NCT04456608 — Predictive Biomarker (PRD): CYP4F11 mRNA
Genes: CYP4F11
Study NCT04456608 — Predictive Biomarker (PRD): PEAR1 mRNA
Genes: PEAR1; MEGF12
Study NCT04456608 — Predictive Biomarker (PRD): ACTN1 mRNA
Genes: ACTN1
Study NCT02359760 — Safety Biomarker (SAF): Interleukin 1
Study NCT03384095 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05688306 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05688306 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT04418388 — Predictive Biomarker (PRD): PBK mRNA
Genes: PBK; TOPK
Study NCT00006264 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04207775 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02597933 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05264090 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04540640 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03605238 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT00728949 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03408626 — Surrogate Endpoint (SUR): Bacterial count
Study NCT00727571 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01019629 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT04552535 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04552535 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02840409 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02840409 — Predictive Biomarker (PRD): KIAA1549 mRNA
Genes: KIAA1549
Study NCT03143101 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02047370 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01057667 — Monitoring Biomarker (MOI): HCV DNA
Study NCT03472183 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00503152 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01655719 — Predictive Biomarker (PRD): PAX8 mRNA
Genes: PAX8
Study NCT03920657 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03233412 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00006237 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00039130 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03572062 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00157092 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT01313416 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01313416 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00637390 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT05127096 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03950245 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03677648 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT00255398 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00237692 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02795260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02795260 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04301882 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00086658 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT01017653 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02561351 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00732069 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT06398678 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT02223247 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study NCT01319591 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01181518 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01181518 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT01181518 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT03062566 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT03062566 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT02362893 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01919333 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02227784 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00212979 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00212979 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00974519 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02891733 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02891733 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study NCT02891733 — Predictive Biomarker (PRD); Safety Biomarker (SAF): NTSR1 mRNA
Genes: NTSR1; NTRR
Study NCT02891733 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02144012 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04586894 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04586894 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT03225183 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study NCT03673488 — Predictive Biomarker (PRD): P4HB mRNA
Genes: P4HB; ERBA2L; PDI; PDIA1; PO4DB
Study NCT00018252 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT04157088 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02664584 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02664584 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02664584 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01988922 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT03179306 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04480788 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT01830361 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01830361 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01152567 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03164720 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT02480764 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03030196 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT03030196 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT01594281 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01594281 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00201019 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02778516 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00914134 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01735149 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01735149 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01735149 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04215601 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00076934 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04423640 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04423640 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02283775 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT01264809 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03411746 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT01193283 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01523171 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT01523171 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study NCT02156999 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03899194 — Predictive Biomarker (PRD): PRKCB mRNA
Genes: PRKCB; PKCB; PRKCB1
Study NCT02745223 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00004244 — Safety Biomarker (SAF): Interleukin 12
Study NCT00824265 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02125266 — Predictive Biomarker (PRD): PTGDS mRNA
Genes: PTGDS; PDS
Study NCT01749137 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02598544 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT01230580 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03832400 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03605043 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04598984 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03392909 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study NCT03558854 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT03558854 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00039273 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03700775 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01964742 — Predictive Biomarker (PRD): ITPA mRNA
Genes: ITPA; C20orf37; My049; OK/SW-cl.9
Study NCT02325271 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02325271 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01411332 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT03308019 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04397107 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01028651 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01028651 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02843334 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT01405898 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02320110 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT04344405 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04344405 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04344405 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04005664 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04797403 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03056859 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04258111 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03819413 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT02066532 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04271514 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study NCT02857270 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study NCT02857270 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT00738452 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04125706 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00500786 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03132792 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT03132792 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT03178084 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02349724 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00056784 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study NCT02689336 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02689336 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02689336 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT01226628 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00001296 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00001296 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03341650 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04301726 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02902016 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study NCT03499704 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03783117 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00387972 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01329770 — Predictive Biomarker (PRD): FMR1 mRNA
Genes: FMR1
Study NCT01089062 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05117437 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT05217147 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05217147 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02002442 — Surrogate Endpoint (SUR): Bacterial count
Study NCT03841214 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT04390178 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02268344 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03977987 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03990363 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02119741 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03476980 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT01223612 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00515645 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02997800 — Surrogate Endpoint (SUR): Blood pressure